PTEN Research is a UK-registered charity. We fund and facilitate research that will lead to new and better treatment for PHTS, a rare genetic condition which currently has no health authority approved therapies. We do this by funding PHTS research projects and bringing together a global network of PHTS focused experts and other key partners. PTEN hamartoma tumour syndrome (PHTS) is a rare genetic disease caused by mutations in the PTEN gene. An individual with a PTEN mutation may be diagnosed as having Cowden Syndrome (CS), Bannayan-Riley-Ruvalcaba Syndrome (BRRS), or Autism Spectrum Disorder (ASD) associated with macrocephaly (large head). Together this spectrum of conditions is known as PHTS. Registered charity number: 1173589
| Website | http://www.ptenresearch.org/ |
| Employees | 13 (6 on RocketReach) |
| Founded | 2016 |
| Address | St James Square, Cheltenham, England GL50 3PR, GB |
| Technologies |
JavaScript
,
HTML
,
Twitter
+11 more
(view full list)
|
| Industry | Research Services |
| Keywords | Rare Disease Research, Genetic Disorder Research, Medical Research Funding, Rare Disease Therapies, Therapeutic Research, Innovative Therapies, Health Research Charity, Disease Research Funding, Genetic Research, Drug Development Research, Research Grants, Scientific Research |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen +36 more (view full list) |
Looking for a particular PTEN Research employee's phone or email?
Thomas Pepper is the Chief Executive and Director of Clinical Development of PTEN Research.
6 people are employed at PTEN Research.
PTEN Research is based in Cheltenham, England.